Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04908319 · ClinicalTrials.gov registry record

Hepatic Histopathology in Urea Cycle Disorders

A clinical trial of Urea Cycle Disorder and Ornithine Transcarbamylase Deficiency, sponsored by Baylor College of Medicine.

Recruiting
Registry status
70
Enrollment target
2
Study locations

NCT04908319 is a study of Urea Cycle Disorder and Ornithine Transcarbamylase Deficiency that is actively recruiting participants, run by Baylor College of Medicine. The registered enrollment target is 70 participants, above the 32-participant average among 4 other Urea Cycle Disorder trials with a reported enrollment target (119% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04908319, a study of Urea Cycle Disorder and Ornithine Transcarbamylase Deficiency, is actively recruiting participants, sponsored by Baylor College of Medicine.

RECRUITING
Registry status
70 participants
Enrollment target
2
Study locations

Study Summary

This is a multi-site, retrospective chart review as well as a prospective study to evaluate histopathologic findings in liver samples from individuals with any UCD diagnosis. This study will be conducted at all Urea Cycle Disorders Consortium (UCDC) sites: Baylor College of Medicine in Houston, TX and Children's National Medical Center in Washington D.C.

Conditions Studied

Urea Cycle Disorder Ornithine Transcarbamylase Deficiency Argininosuccinic Aciduria Hyperargininemia Citrullinemia 1 ARGI Deficiency ASL Deficiency ASS Deficiency Carbamyl Phosphate Synthetase Deficiency NAGS Deficiency

Study Locations (2)

District of Columbia

  • Children's National Medical Center - Washington D.C.

Texas

  • Baylor College of Medicine - Houston

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2022-02-24
Est. Completion 2026-06-30

Sponsor

Baylor College of Medicine

616 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04908319

The ClinicalTrials.gov registry entry for NCT04908319 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 32-participant average among 4 other Urea Cycle Disorder trials with a reported enrollment target (119% higher). The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Urea Cycle Disorder appearing as the primary indexed condition, and to 0 interventions.

NCT04908319 reports 2 study locations spanning 2 distinct geographic areas - top geographies include District of Columbia, Texas.

Frequently Asked Questions

What is clinical trial NCT04908319 about?

NCT04908319 is a clinical study titled "Hepatic Histopathology in Urea Cycle Disorders". This is a multi-site, retrospective chart review as well as a prospective study to evaluate histopathologic findings in liver samples from individuals with any UCD diagnosis. This study will be conducted at all Urea Cycle Disorders Consortium (UCDC) sites: Baylor College of Medicine in Houston, TX a...

What is the current status of trial NCT04908319?

This trial is currently recruiting. The enrollment target is 70 participants. The study started on 2022-02-24. Estimated completion is 2026-06-30.

What conditions does trial NCT04908319 study?

This clinical trial studies the following conditions: Urea Cycle Disorder, Ornithine Transcarbamylase Deficiency, Argininosuccinic Aciduria, Hyperargininemia, Citrullinemia 1.

Who is sponsoring clinical trial NCT04908319?

This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04908319 being conducted?

This trial has 2 study locations across District of Columbia, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Urea Cycle Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Urea Cycle Disorder

All registered trials for this condition

Ornithine Transcarbamylase Deficiency

All registered trials for this condition

District of Columbia

All trials with a study site in District of Columbia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.